DNMT3a promotes proliferation by activating the STAT3 signaling pathway and depressing apoptosis in pancreatic cancer

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Garrido-Laguna I, Hidalgo M. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Nat Rev Clin Oncol. 2015;12(6):319–334. doi:10.1038/nrclinonc.2015.5325824606
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. Jama. 2007;297(3):267–277. doi:10.1001/jama.297.3.26717227978
   PubMed Web of Science ®Google Scholar
• Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–421. doi:10.1038/nature1247723945592
   PubMed Web of Science ®Google Scholar
• Waddell N, Pajic M, Patch AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518(7540):495–501. doi:10.1038/nature1416925719666
   PubMed Web of Science ®Google Scholar
• Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491(7424):399–405. doi:10.1038/nature1154723103869
   PubMed Web of Science ®Google Scholar
• Luczak MW, Jagodzinski PP. The role of DNA methylation in cancer development. Folia Histochem Cytobiol. 2006;44(3):143–154.16977793
   PubMed Web of Science ®Google Scholar
• Ma X, Wang YW, Zhang MQ, Gazdar AF. DNA methylation data analysis and its application to cancer research. Epigenomics. 2013;5(3):301–316. doi:10.2217/epi.13.2623750645
   PubMed Web of Science ®Google Scholar
• Ghavifekr Fakhr M, Farshdousti Hagh M, Shanehbandi D, Baradaran B. DNA methylation pattern as important epigenetic criterion in cancer. Genet Res Int. 2013;2013:317569. doi:10.1155/2013/31756924455281
   PubMedGoogle Scholar
• Sato N, Fukushima N, Hruban RH, Goggins M. CpG island methylation profile of pancreatic intraepithelial neoplasia. Mod Pathol. 2008;21(3):238–244. doi:10.1038/modpathol.380099118157091
   PubMed Web of Science ®Google Scholar
• Oghamian S, Sodir NM, Bashir MU, et al. Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice. Carcinogenesis. 2011;32(6):829–835. doi:10.1093/carcin/bgr03921362628
   PubMed Web of Science ®Google Scholar
• Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C. Cancer genetics of epigenetic genes. Hum Mol Genet. 2007;16 Spec No 1:R28–49. doi:10.1093/hmg/ddm02117613546
   PubMed Web of Science ®Google Scholar
• Ferguson-Smith AC, Greally JM. Epigenetics: perceptive enzymes. Nature. 2007;449(7159):148–149. doi:10.1038/449148a17851501
   PubMed Web of Science ®Google Scholar
• Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet. 1998;19(3):219–220. doi:10.1038/8909662389
   PubMed Web of Science ®Google Scholar
• Peng DF, Kanai Y, Sawada M, et al. Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci. 2005;96(7):403–408. doi:10.1111/j.1349-7006.2005.00071.x16053511
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Zhu Y, Zhu Y, et al. Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2012;14(2):116–124. doi:10.1007/s12094-012-0770-x22301400
   PubMed Web of Science ®Google Scholar
• Gao J, Wang L, Xu J, et al. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression. J Exp Clin Canc Res. 2013;32:86. doi:10.1186/1756-9966-32-86
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene. 2001;20(24):3139–3155. doi:10.1038/sj.onc.120434111420731
   PubMed Web of Science ®Google Scholar
• Li H, Rauch T, Chen ZX, Szabo PE, Riggs AD, Pfeifer GP. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem. 2006;281(28):19489–19500. doi:10.1074/jbc.M51324920016682412
   PubMed Web of Science ®Google Scholar
• Chen BF, Chan WY. The de novo DNA methyltransferase DNMT3A in development and cancer. Epigenetics. 2014;9(5):669–677. doi:10.4161/epi.2832424589714
   PubMed Web of Science ®Google Scholar
• Deng T, Kuang Y, Wang L, Li J, Wang Z, Fei J. An essential role for DNA methyltransferase 3a in melanoma tumorigenesis. Biochem Biophys Res Commun. 2009;387(3):611–616. doi:10.1016/j.bbrc.2009.07.09319632198
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wu Q, Cheng J, Qiu X, Zhang J, Fan H. Depletion of DNMT3A suppressed cell proliferation and restored PTEN in hepatocellular carcinoma cell. J Biomed Biotechnol. 2010;2010:737535. doi:10.1155/2010/73753520467490
   PubMed Web of Science ®Google Scholar
• Cao XY, Ma HX, Shang YH, et al. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer. World J Gastroenterol. 2014;20(25):8201–8208. doi:10.3748/wjg.v20.i25.820125009393
   PubMed Web of Science ®Google Scholar
• He S, Wang F, Yang L, et al. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. PLoS One. 2011;6(11):e27684. doi:10.1371/journal.pone.002768422110720
   PubMed Web of Science ®Google Scholar
• Li Y, Nie Y, Tu S, et al. Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells. Oncol Rep. 2016;36(4):2108–2116. doi:10.3892/or.2016.499627498672
   PubMed Web of Science ®Google Scholar
• Leslie K, Lang C, Devgan G, et al. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res. 2006;66(5):2544–2552. doi:10.1158/0008-5472.CAN-05-220316510571
   PubMed Web of Science ®Google Scholar
• Liu LC, Su CH, Wang HC, et al. Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk. BioMedicine. 2014;4:3. doi:10.7603/s40681-014-0003-425520916
   PubMedGoogle Scholar
• Zhang XM, Zhou C, Gu H, Yan L, Zhang GY. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer. Int J Clin Exp Pathol. 2014;7(9):5902–5908.25337233
   PubMed Web of Science ®Google Scholar
• Wu J, Lu WY, Cui LL. Clinical significance of STAT3 and MAPK phosphorylation, and the protein expression of cyclin D1 in skin squamous cell carcinoma tissues. Mol Med Rep. 2015;12(6):8129–8134. doi:10.3892/mmr.2015.446026497194
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002;285(1–2):1–24.12039028
   PubMed Web of Science ®Google Scholar
• Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 2007;282(28):20059–20063. doi:10.1074/jbc.R70001620017502367
   PubMed Web of Science ®Google Scholar
• Jatiani SS, Baker SJ, Silverman LR, Reddy EP. Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer. 2010;1(10):979–993. doi:10.1177/194760191039718721442038
   PubMedGoogle Scholar
• Lili LN, Matyunina LV, Walker LD, Daneker GW, McDonald JF. Evidence for the importance of personalized molecular profiling in pancreatic cancer. Pancreas. 2014;43(2):198–211. doi:10.1097/MPA.000000000000002024518497
   PubMed Web of Science ®Google Scholar
• Zimmer S, Kahl P, Buhl TM, et al. Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling. J Cancer Res Clin Oncol. 2009;135(5):723–730. doi:10.1007/s00432-008-0509-919002495
   PubMed Web of Science ®Google Scholar
• Chung CD, Liao J, Liu B, et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 1997;278(5344):1803–1805.9388184
   PubMed Web of Science ®Google Scholar
• Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001;19(5):378–387. doi:10.1634/stemcells.19-5-37811553846
   PubMed Web of Science ®Google Scholar
• Wang W, Liu L, Song X, et al. Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation. J Cell Biochem. 2011;112(8):2062–2071. doi:10.1002/jcb.2312521465528
   PubMed Web of Science ®Google Scholar
• Al-Jamal HA, Mat Jusoh SA, Hassan R, Johan MF. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia. BMC Cancer. 2015;15:869. doi:10.1186/s12885-015-1584-326547689
   PubMed Web of Science ®Google Scholar
• Oshimo Y, Kuraoka K, Nakayama H, et al. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int J Cancer. 2004;112(6):1003–1009. doi:10.1002/ijc.2052115386345
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou H, Han Y, et al. SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. J Mol Med. 2014;92(12):1257–1269. doi:10.1007/s00109-014-1184-824996521
   PubMed Web of Science ®Google Scholar
• Huang L, Hu B, Ni J, et al. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. J Exp Clin Canc Res. 2016;35:27. doi:10.1186/s13046-016-0301-7
   PubMed Web of Science ®Google Scholar
• O’Gorman A, Colleran A, Ryan A, Mann J, Egan LJ. Regulation of NF-kappaB responses by epigenetic suppression of IkappaBalpha expression in HCT116 intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2010;299(1):G96–G105. doi:10.1152/ajpgi.00460.200920378831
   PubMed Web of Science ®Google Scholar
• You BR, Park WH. Zebularine inhibits the growth of A549 lung cancer cells via cell cycle arrest and apoptosis. Mol Carcinog. 2014;53(11):847–857. doi:10.1002/mc.2204223661569
   PubMed Web of Science ®Google Scholar
• You BR, Park WH. Zebularine-induced apoptosis in Calu-6 lung cancer cells is influenced by ROS and GSH level changes. Tumour Biol. 2013;34(2):1145–1153. doi:10.1007/s13277-013-0656-823338718
   PubMedGoogle Scholar
• Tan W, Zhou W, Yu HG, Luo HS, Shen L. The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. Biochem Biophys Res Commun. 2013;430(1):250–255. doi:10.1016/j.bbrc.2012.10.14323167995
   PubMed Web of Science ®Google Scholar
• Kurita S, Higuchi H, Saito Y, et al. DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8. Cancer Sci. 2010;101(6):1431–1439. doi:10.1111/j.1349-7006.2010.01565.x20398055
   PubMed Web of Science ®Google Scholar